Bartsch W, Böhm E, Strein K, Sponer G, Müller-Beckmann B, Voss E M
Pharmacological Laboratories, Boehringer Mannheim, Federal Republic of Germany.
J Hypertens Suppl. 1985 Dec;3(3):S203-5.
Comparative haemodynamic investigations with carvedilol and verapamil were carried out on conscious, instrumented dogs. Arterial blood pressure, right atrial pressure (RAP), cardiac output (CO), heart rate, stroke volume and total peripheral resistance (TPR) were determined after intravenous (i.v.) injection of incremental doses (0.01-3 mg/kg) of the drugs. Carvedilol reduced the blood pressure in a dose-dependent manner, concomitant with a reduction in TPR. The RAP and the CO were not affected, indicating that arterial vasodilatation was induced by carvedilol. Verapamil showed a decrease in the blood pressure with a reduction of CO and SV. Moreover, at high doses the RAP was increased, indicating a reduction of the cardiac performance. Thus, in our experimental model remarkable differences between the haemodynamic effects of i.v. injections of carvedilol and verapamil have been observed, whereas after oral administration blood pressure also decreases after verapamil due to a reduction of TPR.
在清醒的、装有仪器的犬身上进行了卡维地洛和维拉帕米的血流动力学比较研究。静脉注射递增剂量(0.01 - 3 mg/kg)的药物后,测定动脉血压、右心房压(RAP)、心输出量(CO)、心率、每搏量和总外周阻力(TPR)。卡维地洛以剂量依赖方式降低血压,同时TPR降低。RAP和CO未受影响,表明卡维地洛引起动脉血管舒张。维拉帕米使血压下降,同时CO和SV降低。此外,高剂量时RAP升高,表明心脏功能降低。因此,在我们的实验模型中,观察到静脉注射卡维地洛和维拉帕米的血流动力学效应存在显著差异,而口服维拉帕米后由于TPR降低血压也会下降。